HTTP 200 OK
Allow: GET
Content-Type: application/json
Vary: Accept
{
"url": "https://lda.senate.gov/api/v1/filings/e1781627-587d-439b-97cd-052dff9cafce/?format=api",
"filing_uuid": "e1781627-587d-439b-97cd-052dff9cafce",
"filing_type": "4A",
"filing_type_display": "4th Quarter - Amendment",
"filing_year": 2025,
"filing_period": "fourth_quarter",
"filing_period_display": "4th Quarter (Oct 1 - Dec 31)",
"filing_document_url": "https://lda.senate.gov/filings/public/filing/e1781627-587d-439b-97cd-052dff9cafce/print/",
"filing_document_content_type": "text/html",
"income": null,
"expenses": "80000.00",
"expenses_method": "A",
"expenses_method_display": "A",
"posted_by_name": "David Sanders",
"dt_posted": "2026-03-09T11:17:44-04:00",
"termination_date": null,
"registrant_country": "United States of America",
"registrant_ppb_country": "United States of America",
"registrant_address_1": "333 Twin Dolphin Drive",
"registrant_address_2": "Suite 600",
"registrant_different_address": false,
"registrant_city": "Redwood City",
"registrant_state": "CA",
"registrant_zip": "94065",
"registrant": {
"id": 401103810,
"url": "https://lda.senate.gov/api/v1/registrants/401103810/?format=api",
"house_registrant_id": null,
"name": "COHERUS BIOSCIENCES, INC.",
"description": "lobbying, advocacy, pharmaceutical company",
"address_1": "333 Twin Dolphin Drive",
"address_2": "Suite 600",
"address_3": null,
"address_4": null,
"city": "Redwood City",
"state": "CA",
"state_display": "California",
"zip": "94065",
"country": "US",
"country_display": "United States of America",
"ppb_country": "US",
"ppb_country_display": "United States of America",
"contact_name": "DAVID SANDERS",
"contact_telephone": "+1 202-422-2375",
"dt_updated": "2026-03-09T11:03:03.515264-04:00"
},
"client": {
"id": 200183,
"url": "https://lda.senate.gov/api/v1/clients/200183/?format=api",
"client_id": 12,
"name": "COHERUS BIOSCIENCES, INC.",
"general_description": null,
"client_government_entity": false,
"client_self_select": true,
"state": "CA",
"state_display": "California",
"country": "US",
"country_display": "United States of America",
"ppb_state": "CA",
"ppb_state_display": "California",
"ppb_country": "US",
"ppb_country_display": "United States of America",
"effective_date": "2020-08-01"
},
"lobbying_activities": [
{
"general_issue_code": "HCR",
"general_issue_code_display": "Health Issues",
"description": "Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production",
"foreign_entity_issues": "",
"lobbyists": [
{
"lobbyist": {
"id": 80167,
"prefix": null,
"prefix_display": null,
"first_name": "DAVID",
"nickname": null,
"middle_name": null,
"last_name": "SANDERS",
"suffix": null,
"suffix_display": null
},
"covered_position": "Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)",
"new": false
}
],
"government_entities": [
{
"id": 136,
"name": "Centers For Medicare and Medicaid Services (CMS)"
},
{
"id": 25,
"name": "Defense, Dept of (DOD)"
},
{
"id": 11,
"name": "Executive Office of the President (EOP)"
},
{
"id": 135,
"name": "Food & Drug Administration (FDA)"
},
{
"id": 34,
"name": "Health & Human Services, Dept of (HHS)"
},
{
"id": 2,
"name": "HOUSE OF REPRESENTATIVES"
},
{
"id": 18,
"name": "Office of Management & Budget (OMB)"
},
{
"id": 21,
"name": "Office of Science & Technology Policy (OSTP)"
},
{
"id": 1,
"name": "SENATE"
},
{
"id": 12,
"name": "White House Office"
}
]
},
{
"general_issue_code": "GOV",
"general_issue_code_display": "Government Issues",
"description": "Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.",
"foreign_entity_issues": "",
"lobbyists": [
{
"lobbyist": {
"id": 80167,
"prefix": null,
"prefix_display": null,
"first_name": "DAVID",
"nickname": null,
"middle_name": null,
"last_name": "SANDERS",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": false
}
],
"government_entities": [
{
"id": 136,
"name": "Centers For Medicare and Medicaid Services (CMS)"
},
{
"id": 24,
"name": "Commerce, Dept of (DOC)"
},
{
"id": 116,
"name": "Defense Advanced Research Projects Agency (DARPA)"
},
{
"id": 48,
"name": "Defense Nuclear Facilities Safety Board"
},
{
"id": 33,
"name": "Energy, Dept of"
},
{
"id": 11,
"name": "Executive Office of the President (EOP)"
},
{
"id": 56,
"name": "Federal Emergency Management Agency (FEMA)"
},
{
"id": 135,
"name": "Food & Drug Administration (FDA)"
},
{
"id": 34,
"name": "Health & Human Services, Dept of (HHS)"
},
{
"id": 2,
"name": "HOUSE OF REPRESENTATIVES"
},
{
"id": 16,
"name": "Natl Security Council (NSC)"
},
{
"id": 18,
"name": "Office of Management & Budget (OMB)"
},
{
"id": 9,
"name": "President of the U.S."
},
{
"id": 1,
"name": "SENATE"
},
{
"id": 10,
"name": "Vice President of the U.S."
},
{
"id": 12,
"name": "White House Office"
}
]
}
],
"conviction_disclosures": [],
"foreign_entities": [],
"affiliated_organizations": []
}